Joint pain and Shock

Summary:

Shock is found among people with Joint pain, especially for people who are female, 60+ old.

The study analyzes which people have Shock with Joint pain. It is created by eHealthMe based on reports of 94 people who have Joint pain from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Joint pain?

Joint pain is found to be associated with 3,331 drugs and 5,204 conditions by eHealthMe. Check the latest studies of Joint pain.

What is Shock?

Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin) is found to be associated with 1,218 drugs and 1,753 conditions by eHealthMe. Check the latest studies of Shock.



On Jul, 15, 2026

94 people who have Joint Pain and Shock are studied.

Would you have Shock when you have Joint pain?

Gender of people who have Joint Pain and experienced Shock *:

  • female: 71.59 %
  • male: 28.41 %

Age of people who have Joint Pain and experienced Shock *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.75 %
  • 20-29: 2.5 %
  • 30-39: 3.75 %
  • 40-49: 8.75 %
  • 50-59: 10.0 %
  • 60+: 71.25 %

Common co-existing conditions for these people *:

  1. Blockage Of Leg Arteries: 20 people, 21.28%
  2. Immunodeficiency Disorders: 12 people, 12.77%
  3. Pain: 6 people, 6.38%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 4.26%
  5. Headache (pain in head): 3 people, 3.19%
  6. Malignant Melanoma (skin cancer rises from melancytes): 3 people, 3.19%
  7. High Blood Pressure: 3 people, 3.19%
  8. Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 3.19%
  9. Dyspnea (difficult or laboured breathing): 3 people, 3.19%
  10. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 2 people, 2.13%

Common drugs taken by these people *:

  1. Diclofenac: 19 people, 20.21%
  2. Vioxx: 19 people, 20.21%
  3. Voltaren: 11 people, 11.70%
  4. Aspirin: 9 people, 9.57%
  5. Tacrolimus: 8 people, 8.51%
  6. Azathioprine: 6 people, 6.38%
  7. Celebrex: 5 people, 5.32%
  8. Norvasc: 5 people, 5.32%
  9. Aleve: 5 people, 5.32%
  10. Alendronate Sodium: 4 people, 4.26%

Common symptoms for these people *:

  1. Renal Impairment (severely reduced kidney function): 19 people, 20.21%
  2. Hypotension (abnormally low blood pressure): 17 people, 18.09%
  3. Graft Loss (graft failure): 16 people, 17.02%
  4. Dizziness: 15 people, 15.96%
  5. Death: 11 people, 11.70%
  6. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 11 people, 11.70%
  7. Heart Attack: 11 people, 11.70%
  8. Dyspnea (difficult or laboured breathing): 10 people, 10.64%
  9. Coronary Artery Stenosis (narrowing of coronary artery): 9 people, 9.57%
  10. Graft Thrombosis (clotting at graft): 9 people, 9.57%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Shock?

- Check whether Shock is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Shock:

All the conditions that are associated with Shock:

  • Shock (1,753 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Shock and Joint pain, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: